ketanserin has been researched along with Tobacco Use Disorder in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Tobacco Use Disorder: Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, ED | 1 |
| Slade, S | 1 |
| Johnson, M | 1 |
| Petro, A | 1 |
| Horton, K | 1 |
| Williams, P | 1 |
| Rezvani, AH | 1 |
| Rose, JE | 1 |
1 other study available for ketanserin and Tobacco Use Disorder
| Article | Year |
|---|---|
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ketanseri | 2008 |